| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Kooij Louise Frederika | Chief Accounting Officer | C/O NEWAMSTERDAM PHARMA COMPANY N.V., GOOIMEER 2-35, NAARDEN, NETHERLANDS | /s/ Louise Kooij | 05 Sep 2025 | 0002004379 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NAMS | Ordinary Shares | Sale | $453,452 | -18,073 | -55% | $25.09 | 15,000 | 03 Sep 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price provided by the broker; additional information, including the price range, if any, is unavailable at the time of filing. |